Axogen (AXGN) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.38% |
| Dec 31, 2025 | 0.91% |
| Sep 30, 2025 | -0.15% |
| Jun 30, 2025 | -1.28% |
| Mar 31, 2025 | -3.23% |
| Dec 31, 2024 | -4.70% |
| Sep 30, 2024 | -5.99% |
| Jun 30, 2024 | -7.06% |
| Mar 31, 2024 | -7.92% |
| Dec 31, 2023 | -8.23% |
| Sep 30, 2023 | -8.13% |
| Jun 30, 2023 | -8.38% |
| Mar 31, 2023 | 35.07% |
| Dec 31, 2022 | 32.02% |
| Sep 30, 2022 | 57.25% |
| Jun 30, 2022 | 55.16% |
| Mar 31, 2022 | 53.66% |
| Dec 31, 2021 | 49.80% |
| Sep 30, 2021 | 153.39% |
| Jun 30, 2021 | 111.68% |
| Mar 31, 2021 | 89.96% |
| Dec 31, 2020 | 71.94% |
| Sep 30, 2020 | 61.22% |
| Jun 30, 2020 | 104.68% |
| Mar 31, 2020 | 183.92% |
| Dec 31, 2019 | 68.92% |
| Sep 30, 2019 | 72.55% |
| Jun 30, 2019 | 84.24% |
| Mar 31, 2019 | 109.25% |
| Dec 31, 2018 | 303.96% |
| Sep 30, 2018 | 105.14% |
| Jun 30, 2018 | 78.63% |
| Mar 31, 2018 | 41.20% |
| Dec 31, 2017 | 61.24% |
| Sep 30, 2017 | 54.34% |
| Jun 30, 2017 | 28.16% |
| Mar 31, 2017 | 24.10% |
| Dec 31, 2016 | 19.70% |
| Sep 30, 2016 | -32.64% |
| Jun 30, 2016 | -24.71% |
| Dec 31, 2015 | 18.15% |